Literature DB >> 17321015

Current status of TB vaccines.

Umesh Datta Gupta1, Vishwa Mohan Katoch, David N McMurray.   

Abstract

During last 10 years, there has been extensive work for the development of potential tuberculosis vaccine candidates using the mice and guinea pig models. Though till date several promising candidates have been identified and at least eight vaccines have entered clinical evaluation. These recent advances in the clinical testing of new TB vaccines are very exciting and promising. However, there is a need to continue the search for additional vaccine candidates or vaccination strategies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17321015     DOI: 10.1016/j.vaccine.2007.01.112

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  36 in total

1.  A novel recombinant human lactoferrin augments the BCG vaccine and protects alveolar integrity upon infection with Mycobacterium tuberculosis in mice.

Authors:  Shen-An Hwang; Katarzyna Wilk; Marian L Kruzel; Jeffrey K Actor
Journal:  Vaccine       Date:  2009-04-05       Impact factor: 3.641

2.  Design and Construction of a Cloning Vector Containing the hspX Gene of Mycobacterium tuberculosis.

Authors:  Atieh Yaghoubi; Ehsan Aryan; Hosna Zare; Shadi Alami; Roghayeh Teimourpour; Zahra Meshkat
Journal:  Rep Biochem Mol Biol       Date:  2016-10

3.  Designing and Construction of a DNA Vaccine Encoding Tb10.4 Gene of Mycobacterium tuberculosis.

Authors:  Samira Rashidian; Roghayeh Teimourpour; Zahra Meshkat
Journal:  Iran J Pathol       Date:  2016

4.  Construction of a Novel DNA Vaccine Candidate Encoding an HspX-PPE44-EsxV Fusion Antigen of Mycobacterium tuberculosis.

Authors:  Bagher Moradi; Mojtaba Sankian; Yousef Amini; Zahra Meshkat
Journal:  Rep Biochem Mol Biol       Date:  2016-04

5.  Preclinical study and clinical trial of a novel therapeutic vaccine against multi-drug resistant tuberculosis.

Authors:  Masaji Okada; Yoko Kita; Satomi Hashimoto; Hitoshi Nakatani; Shiho Nishimastu; Yumiko Kioka; Yasuko Takami
Journal:  Hum Vaccin Immunother       Date:  2016-12-14       Impact factor: 3.452

6.  Novel therapeutic vaccines [(HSP65 + IL-12)DNA-, granulysin- and Ksp37-vaccine] against tuberculosis and synergistic effects in the combination with chemotherapy.

Authors:  Yoko Kita; Satomi Hashimoto; Toshihiro Nakajima; Hitoshi Nakatani; Shiho Nishimatsu; Yasuko Nishida; Noriko Kanamaru; Yasuhumi Kaneda; Yasushi Takamori; David McMurray; Esterlina V Tan; Marjorie L Cang; Paul Saunderson; E C Dela Cruz; Masaji Okada
Journal:  Hum Vaccin Immunother       Date:  2012-12-18       Impact factor: 3.452

7.  Helminth coinfection does not affect therapeutic effect of a DNA vaccine in mice harboring tuberculosis.

Authors:  Fabiani G Frantz; Rogério S Rosada; Camila Peres-Buzalaf; Franciele R T Perusso; Vanderlei Rodrigues; Simone G Ramos; Steven L Kunkel; Célio L Silva; Lúcia H Faccioli
Journal:  PLoS Negl Trop Dis       Date:  2010-06-08

8.  Lactoferrin modulation of BCG-infected dendritic cell functions.

Authors:  Shen-An Hwang; Jeffrey K Actor
Journal:  Int Immunol       Date:  2009-08-19       Impact factor: 4.823

9.  CD1-restricted adaptive immune responses to Mycobacteria in human group 1 CD1 transgenic mice.

Authors:  Kyrie Felio; Hanh Nguyen; Christopher C Dascher; Hak-Jong Choi; Sha Li; Michael I Zimmer; Angela Colmone; D Branch Moody; Michael B Brenner; Chyung-Ru Wang
Journal:  J Exp Med       Date:  2009-10-05       Impact factor: 14.307

10.  Complex cytokine profiles induced by BCG vaccination in UK infants.

Authors:  Maeve K Lalor; Steven G Smith; Sian Floyd; Patricia Gorak-Stolinska; Rosemary E Weir; Rose Blitz; Keith Branson; Paul E Fine; Hazel M Dockrell
Journal:  Vaccine       Date:  2009-11-24       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.